As of 2025-09-16, the Intrinsic Value of Oncolytics Biotech Inc (ONC.TO) is -1.71 CAD. This ONC.TO valuation is based on the model Peter Lynch Fair Value. With the current market price of 1.42 CAD, the upside of Oncolytics Biotech Inc is -220.56%.
Based on its market price of 1.42 CAD and our intrinsic valuation, Oncolytics Biotech Inc (ONC.TO) is overvalued by 220.56%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -1.71 - -1.71 | -1.71 | -220.56% |
| P/E | (0.03) - (0.07) | (0.03) | -102.4% |
| DDM - Stable | (3.68) - (14.58) | (9.13) | -742.7% |
| DDM - Multi | (0.06) - (0.19) | (0.09) | -106.5% |
| Market Cap (mil) | 126.12 |
| Beta | 0.89 |
| Outstanding shares (mil) | 88.82 |
| Enterprise Value (mil) | 122.96 |
| Market risk premium | 5.10% |
| Cost of Equity | 8.32% |
| Cost of Debt | 5.00% |
| WACC | 8.29% |